Back to Results
First PageMeta Content
Chemistry / Oseltamivir / Vaccines / Health / Influenza / Adverse event / FluMist / Acetamides / Neuraminidase inhibitors / Medicine


Tamiflu Safety Update – 2007 Linda L. Lewis, M.D. Division of Antiviral Products CDER, FDA Outline
Add to Reading List

Document Date: 2007-12-06 16:38:24


Open Document

File Size: 57,85 KB

Share Result on Facebook

Company

AEs / pediatric AE / /

Country

Japan / United States / Canada / /

MedicalCondition

Loss of consciousness / psychological disorder / viral encephalitis / flu / Panic attack / encephalopathy beginning / influenza-associated encephalitis / uncomplicated influenza / Depressed level of consciousness / CNS inflammation / psychiatric disorders / encephalopathy / encephalitis / Delirium / depression / influenza / Syndrome / influenza B / /

MedicalTreatment

Medication errors / /

OperatingSystem

OSE / /

Organization

BPCA Pediatric Advisory Committee / FDA / Japanese national health service / Division of Antiviral Products CDER / /

Person

Linda L. Lewis / Lack / /

Position

reporting physician / /

Product

Tamiflu / /

Technology

pharmacogenomic / drug metabolism / /

SocialTag